Enhancing radiation response by a second-generation TRAIL receptor agonist using a new in vitro organoid model system

by Shuraila F. Zerp, Zainab Bibi, Inge Verbrugge, Emile E. Voest, Marcel Verheij
Published 2020-09-01

Learning health care systems: Highly needed but challenging

by Roel H.P. Wouters, Rieke van derGraaf, Emile E. Voest, Annelien L. Bredenoord
Published 2020-07-01

Phase 1/2 Study of Atrasentan Combined with Pegylated Liposomal Doxorubicin in Platinum-Resistant Recurrent Ovarian Cancer

by Petronella O. Witteveen, Koen J.C. van der Mijn, Maartje Los, Roelien H. Kronemeijer, Gerard Groenewegen, Emile E. Voest
Published 2010-11-01

Late Release of Circulating Endothelial Cells and Endothelial Progenitor Cells after Chemotherapy Predicts Response and Survival in Cancer Patients

by Jeanine M. Roodhart, Marlies H. Langenberg, Joost S. Vermaat, Martijn P. Lolkema, Arnold Baars, Rachel H. Giles, Els O. Witteveen, Emile E. Voest
Published 2010-01-01

Patient-Derived Organoid Models of Human Neuroendocrine Carcinoma

by Krijn K. Dijkstra, Krijn K. Dijkstra, José G. van den Berg, Fleur Weeber, Fleur Weeber, Joris van de Haar, Joris van de Haar, Arno Velds, Sovann Kaing, Sovann Kaing, Dennis D. G. C. Peters, Ferry A. L. M. Eskens, Derk-Jan A. de Groot, Margot E. T. Tesselaar, Emile E. Voest, Emile E. Voest
Published 2021-03-01

Challenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized Medicine

by Krijn K. Dijkstra, Kim Monkhorst, Luuk J. Schipper, Koen J. Hartemink, Egbert F. Smit, Sovann Kaing, Rosa de Groot, Monika C. Wolkers, Hans Clevers, Edwin Cuppen, Emile E. Voest
Published 2020-05-01

Phase 1 Study of Combination Treatment with PTK 787/ZK 222584 and Cetuximab for Patients with Advanced Solid Tumors: Safety, Pharmacokinetics, Pharmacodynamics Analysis

by Marlies H.G. Langenberg, Petronella O. Witteveen, Nienke A.G. Lankheet, Jeanine M.L. Roodhart, Hilde Rosing, Ingeborg J.G.M. van den Heuvel, Jos H. Beijnen, Emile E. Voest
Published 2010-02-01

Partner independent fusion gene detection by multiplexed CRISPR-Cas9 enrichment and long read nanopore sequencing

by Christina Stangl, Sam de Blank, Ivo Renkens, Liset Westera, Tamara Verbeek, Jose Espejo Valle-Inclan, Rocio Chamorro González, Anton G. Henssen, Markus J. van Roosmalen, Ronald W. Stam, Emile E. Voest, Wigard P. Kloosterman, Gijs van Haaften, Glen R. Monroe
Published 2020-06-01

Exploring gene expression signatures for predicting disease free survival after resection of colorectal cancer liver metastases.

by Nikol Snoeren, Sander R van Hooff, Rene Adam, Richard van Hillegersberg, Emile E Voest, Catherine Guettier, Paul J van Diest, Maarten W Nijkamp, Mariel O Brok, Dik van Leenen, Marian J A Groot Koerkamp, Frank C P Holstege, Inne H M Borel Rinkes
Published 2012-01-01

Mutations in LRRC50 predispose zebrafish and humans to seminomas.

by Sander G Basten, Erica E Davis, Ad J M Gillis, Ellen van Rooijen, Hans Stoop, Nikolina Babala, Ive Logister, Zachary G Heath, Trudy N Jonges, Nicholas Katsanis, Emile E Voest, Freek J van Eeden, Rene H Medema, René F Ketting, Stefan Schulte-Merker, Leendert H J Looijenga, Rachel H Giles
Published 2013-04-01

Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE)

by Kris G. Samsom, Linda J. W. Bosch, Luuk J. Schipper, Paul Roepman, Ewart de Bruijn, Louisa R. Hoes, Immy Riethorst, Lieke Schoenmaker, Lizet E. van der Kolk, Valesca P. Retèl, Geert W. J. Frederix, Tineke E. Buffart, Jacobus J. M. van der Hoeven, Emile E. Voest, Edwin Cuppen, Kim Monkhorst, Gerrit A. Meijer
Published 2020-11-01

Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded...

by Wendy W J de Leng, Christa G Gadellaa-van Hooijdonk, Françoise A S Barendregt-Smouter, Marco J Koudijs, Ies Nijman, John W J Hinrichs, Edwin Cuppen, Stef van Lieshout, Robert D Loberg, Maja de Jonge, Emile E Voest, Roel A de Weger, Neeltje Steeghs, Marlies H G Langenberg, Stefan Sleijfer, Stefan M Willems, Martijn P Lolkema
Published 2016-01-01

BRAFV600E Kinase Domain Duplication Identified in Therapy-Refractory Melanoma Patient-Derived Xenografts

by Kristel Kemper, Oscar Krijgsman, Xiangjun Kong, Paulien Cornelissen-Steijger, Aida Shahrabi, Fleur Weeber, Daphne L. van der Velden, Onno B. Bleijerveld, Thomas Kuilman, Roel J.C. Kluin, Chong Sun, Emile E. Voest, Young Seok Ju, Ton N.M. Schumacher, A.F. Maarten Altelaar, Ultan McDermott, David J. Adams, Christian U. Blank, John B. Haanen, Daniel S. Peeper
Published 2016-06-01

The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact

by Lisanne F. van Dessel, Job van Riet, Minke Smits, Yanyun Zhu, Paul Hamberg, Michiel S. van der Heijden, Andries M. Bergman, Inge M. van Oort, Ronald de Wit, Emile E. Voest, Neeltje Steeghs, Takafumi N. Yamaguchi, Julie Livingstone, Paul C. Boutros, John W. M. Martens, Stefan Sleijfer, Edwin Cuppen, Wilbert Zwart, Harmen J. G. van de Werken, Niven Mehra, Martijn P. Lolkema
Published 2019-11-01